Bank Of New York Mellon Corp Deciphera Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$14.26 - $22.1 $2.71 Million - $4.2 Million	189,824 New	189,824 $2.93 Billion
Q4 2022 Feb 14, 2023	BUY	$14.85 - $19.04 $2.61 Million - $3.34 Million	175,507 New	175,507 $2.88 Million
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $224,895 - $367,498	18,166 Added 11.97%	169,928 $3.14 Million
Q2 2022 Aug 15, 2022	BUY	$9.11 - $13.98 $75,285 - $115,530	8,264 Added 5.76%	151,762 $2 Million
Q1 2022 May 11, 2022	BUY	$6.87 - $11.11 $44,380 - $71,770	6,460 Added 4.71%	143,498 $1.33 Million
Q4 2021 Feb 11, 2022	SELL	$7.7 - $37.13 $229,075 - $1.1 Million	-29,750 Reduced 17.84%	137,038 $1.34 Million
Q3 2021 Nov 12, 2021	BUY	$26.46 - $37.15 $224,830 - $315,663	8,497 Added 5.37%	166,788 $5.67 Million
Q2 2021 Aug 11, 2021	SELL	$32.73 - $47.95 $760,088 - $1.11 Million	-23,223 Reduced 12.79%	158,291 $5.8 Million
Q1 2021 May 13, 2021	SELL	$40.39 - $56.73 $247,429 - $347,527	-6,126 Reduced 3.26%	181,514 $8.14 Million
Q4 2020 Feb 09, 2021	BUY	$51.77 - $66.18 $741,035 - $947,300	14,314 Added 8.26%	187,640 $10.7 Million
Q3 2020 Nov 12, 2020	BUY	$43.8 - $58.16 $168,016 - $223,101	3,836 Added 2.26%	173,326 $8.89 Million
Q2 2020 Aug 12, 2020	BUY	$37.05 - $65.03 $1.8 Million - $3.15 Million	48,493 Added 40.08%	169,490 $10.1 Million
Q1 2020 May 06, 2020	BUY	$33.63 - $69.4 $151,435 - $312,508	4,503 Added 3.87%	120,997 $4.98 Million
Q4 2019 Feb 14, 2020	BUY	$31.7 - $69.93 $627,723 - $1.38 Million	19,802 Added 20.48%	116,494 $7.25 Million
Q3 2019 Nov 07, 2019	BUY	$19.95 - $38.85 $762,568 - $1.49 Million	38,224 Added 65.38%	96,692 $3.28 Million
Q2 2019 Aug 12, 2019	BUY	$21.05 - $26.21 $238,749 - $297,273	11,342 Added 24.07%	58,468 $1.32 Million
Q1 2019 May 14, 2019	BUY	$20.65 - $29.55 $8,714 - $12,470	422 Added 0.9%	47,126 $1.09 Million
Q4 2018 Feb 11, 2019	SELL	$19.08 - $36.14 $375,952 - $712,102	-19,704 Reduced 29.67%	46,704 $981,000
Q3 2018 Nov 09, 2018	BUY	$33.57 - $42.1 $334,558 - $419,568	9,966 Added 17.66%	66,408 $0
Q2 2018 Aug 06, 2018	BUY	$20.06 - $44.95 $659,532 - $1.48 Million	32,878 Added 139.53%	56,442 $2.22 Million
Q1 2018 May 15, 2018	BUY	$20.04 - $29.71 $129,839 - $192,491	6,479 Added 37.92%	23,564 $472,000
Q4 2017 Feb 09, 2018	BUY	$16.54 - $24.2 $282,585 - $413,457	17,085	17,085 $388,000

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account